In addition, TR1 vs. CTR had downregulated immune-associated pathways (antigen processing and presentation, graft-versus-host disease, and allograft rejection), as well as downregulated metabolic pathways (glycine, serine and threonine metabolism, metabolic pathways, biosynthesis of amino acids, and carbon metabolism). Here, TXNRD1 is linked to graft versus host disease.